» Articles » PMID: 38444846

Exploring the ROS Reduction Strategies in Chronic Lupus Management

Overview
Journal Front Immunol
Date 2024 Mar 6
PMID 38444846
Authors
Affiliations
Soon will be listed here.
References
1.
Olsson L, Johansson A, Gullstrand B, Jonsen A, Saevarsdottir S, Ronnblom L . A single nucleotide polymorphism in the gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann Rheum Dis. 2017; 76(9):1607-1613. DOI: 10.1136/annrheumdis-2017-211287. View

2.
Tian J, Zhang D, Yao X, Huang Y, Lu Q . Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2022; 82(3):351-356. PMC: 9933169. DOI: 10.1136/ard-2022-223035. View

3.
Kelkka T, Kienhofer D, Hoffmann M, Linja M, Wing K, Sareila O . Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxid Redox Signal. 2014; 21(16):2231-45. PMC: 4224049. DOI: 10.1089/ars.2013.5828. View

4.
Pan L, Lu M, Wang J, Xu M, Yang S . Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2019; 16(1):19-30. PMC: 7040062. DOI: 10.1007/s12519-019-00229-3. View

5.
Davis L, Reimold A . Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus. Rheumatology (Oxford). 2017; 56(suppl_1):i100-i113. PMC: 5850311. DOI: 10.1093/rheumatology/kew417. View